Share：
Share this content in WeChat
X
[Chinese][PDF]90665
• Review •
Research in magnetic resonance imaging of triple-negative breast cancer
WANG Qi  CHANG Xiao-dan 

DOI:10.3969/j.issn.1674-8034.2015.01.014.


[Abstract] Triple-negative breast cancer (TNBC), which characterized by distinct biological and clinical pathological features, has a worse prognosis because of the lack of effective therapeutic targets. Breast MR is the most accurate imaging modality for diagnosis of breast cancer currently. MR imaging recognition could assist in diagnosis, pretreatment planning and prognosis evaluation of TNBC. MR findings of a larger solitary lesion, mass with smooth mass margin, high signal intensity on T2-weighted images and rim enhancement are typical MRI features associated with TNBC. Further work is necessary about the clinical application of dynamic contrast-enhanced MR imaging (DCE-MRI), DWI and MRS.
[Keywords] Breast neoplasms；Magnetic resonance imaging；Pathology

WANG Qi Department of Radiology, Dalian University, Zhongshan Hospital, Dalian 116001, China

CHANG Xiao-dan* Department of Radiology, Dalian University, Zhongshan Hospital, Dalian 116001, China

*Correspondence to: Chang XD, E-mail: 13384111832@163.com

Conflicts of interest   None.

Received  2014-08-26
Accepted  2014-10-30
DOI: 10.3969/j.issn.1674-8034.2015.01.014
DOI:10.3969/j.issn.1674-8034.2015.01.014.

[1]
Brenton JD, Carey L, Ahmed AA, et al. Molecular classification and molecular forecasting of breast cancer:ready for clinical application? J Clin Oncol, 2005, 23(29): 7350-7360.
[2]
Dent R, Hanna WM, Trudeau M, et al. Pattern of metastatic spread in triple-negative breast cancer.Breast Cancer Res Treat, 2009, 115(2): 423-428.
[3]
Jung SY, Kim HY, Nam BH, et al. Worse prognosis of metaplastic breast cancer patients than other patients with triple-negative breast cancer. Breast Cancer Res Treat, 2010, 120(3): 627-637.
[4]
Amirikia KC, Mills P, Busn J, et al. Higher population-based incidence rates of triple-negative breast cancer among young African-American women: implications for breast cancer screening recommendations. Cancer, 2011, 117(12): 2747-2753.
[5]
Dogan BE, Turnbull LW. Imaging of triple-negative breast cancer. Ann Oncol, 2012, 23(Suppl 6): vi23-29.
[6]
胡静，汪登斌，柴维敏，等．三阴性乳腺癌的MRI影像学特点分析.放射学实践, 2010, 25(9): 1011-1015.
[7]
Perou CM, Sørlie T, Eisen MB, et al. Molecular portraits of human breast tumours. Nature, 2000, 406(6797):747-752.
[8]
王盈盈，常晓丹，付娇慧．乳腺浸润性导管癌3.0 T MRI表现与预后因子相关性研究．磁共振成像, 2014, 5(2): 132-137.
[9]
Reis-Filho JS, Tutt AN. Triple negative tumours:a critical review. Histopathology, 2008, 52(1): 108-118.
[10]
Nielsen TO, Hsu FD, Jensen K, et al. Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma. Clin Cancer RES, 2004, 10(16): 5367-5374.
[11]
Kojima Y, Tsunoda H, Honda S, et al. Radiographic features for triple negative ductal carcinoma in situ of the breast. Breast Cancer, 2011, 18(3): 213-220.
[12]
Dent R, Trudeau M, Pritchard KI, et al. Triple-negative breast cancer:clinical features and patterns of recurrence. Clin Cancer Res, 2007, 13(15Pt 1): 4429-4434.
[13]
Dent R, Hanna WM, Trudeau M, et al. Pattern of metastatic spread in triple-negative breast cancer. Breast Cancer Res Treat, 2009, 115(2): 423-428.
[14]
Rodríguez-Pinilla SM, Sarrió D, Honrado E, et al. Prognostic significance of basal-like phenotype and fascin expression in nodenegative invasive breast carcinomas. Clin Cancer Res, 2006, 12(5): 1533-1539.
[15]
李志新，张冰，顾梅，等．三阴性乳腺癌临床病理特征及诊治分析.中国肿瘤临床与康复, 2011, 18 (4): 305-308.
[16]
张青，王振常，鲜军舫，等．乳腺癌增强MRI特征与病理、免疫组化指标的相关性研究．磁共振成像, 2012, 3(6): 430-433.
[17]
Dogan BE, Gonzalez-Angulo AM. Gilcrease M, et al. Multimodality imaging of triple recepor-negative tumors with mammography,ultrasound,and MRI. AJR Am J Roentgenol, 2010, 194(4): 1160-1166.
[18]
Uematsu T, Kasami M, Yuen S, et al. Triple-negation breast cancer:correlation between MR imaging and pathological findings. Radiology, 2009, 250(3): 638-647.
[19]
Youk JH, Son EJ, Chung J, et al. Triple-negative invasive breast cancer on dynamic contrast-enhanced and diffusion-weighted MR imaging:comparison with other breast cancer subtypes. Eur Radiol, 2012, 22(8): 1724-1734.
[20]
Chen JH, Agrawal G, Feig B, et al. Triple-negative breast cancer:MRI features in 29 patients. Ann Oncol, 2007, 18(12): 2042-2043.
[21]
Sung JS, Jochelson MS, Brennan S, et al. MR imaging features of triple-negative breast cancers. Breast, 2013, 19(6): 643-649.
[22]
Su MY, Chen JH．动态增强磁共振成像在乳腺癌诊断及疗效监测中的应用进展．磁共振成像, 2012, 3(2): 84-97.
[23]
Teifke A, Behr O, Schmidt M, et al. Dynamic MR imaging ofbreast lesions:correlation with microvessel distribution pattern and histologic characteristics of prognosis. Radiology, 2006, 239(2): 351-360.
[24]
Kuhl CK, Mielearek P, Klasehil S, et al. Dynamic breast MR imaging:are signal time course data useful for diferential diagnosis of enhancing lesions. Radiology, 1999, 211(1): 101-110.
[25]
阮超美，欧阳翼，陈林，等．乳腺动态增强MR中时间-信号曲线的第四种类型．医学争鸣, 2008, 29(24): 2211-2213.
[26]
谷爽，苏天昊，靳二虎，等．乳腺MRI动态增强扫描Ⅰ型曲线的临床意义．磁共振成像, 2011, 2(3): 190-194.
[27]
Whitman GJ, Albarracin CT, Gonzalez-Angulo AM. Triple negative breast cancer: what the radiologist needs to know. Semin Roentgenol, 2011, 46(1): 26-39.
[28]
Li SP, Padhani AR, Taylor NJ, et al. Vascular characterization of triple negative breast carcinomas using dynamic MRI. Eur Radiol, 2011, 21(7): 1364-1373.
[29]
Yoshikawa MI, Ohsumi S, Sugata S, et al. Relation between cancer cellularity and apparent diffusion coefficient values using diffusion-weighted magnetic resonance imaging in breast cancer. Radiat Med, 2008, 26(4): 222-226.
[30]
何之彦, Mangroo A,李志宇，等. 3.0 T MR扩散加权和动态增强对乳腺小肿块病灶的诊断价值．磁共振成像, 2012, 3(2): 120-124.
[31]
尹媛媛，王宏，穆学涛. MRI在乳腺癌新辅助化疗疗效评估中的应用研究．磁共振成像, 2013, 4(6): 476-480.
[32]
Bartella L, Huang W. Proton (1H) MR spectroscopy of the breast. Radiographics, 2007, 27(Suppl 1): S241-S252.
[33]
Meisamy S, Bolan PJ, Baker EH, et al. Adding in vivo quantitative 1H MR spectroscopy to improve diagnostic accuracy of breast MR imaging: preliminary results of observer performance study at 4.0 T. Radiology, 2005, 236(2): 465-475.
[34]
Chen JH, Mehta RS, Baek HM, et al. Clinical characteristics and biomarkers of breast cancer associated with choline concentration measured by 1H MRS. NMR Biomed, 2011, 24(3):316-324.
[35]
Leach MO, Boggis CR, Dixon AK, et al. Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multi-centre cohort study (MARIBS). Lancet, 2005, 365(9473): 1769-1778.
[36]
Lu H, Xu YL, Zhang SP, et al. Breast magnetic resonance imaging in patients with occult breast carcinoma: evaluation on feasibility and correlation with histopathological findings. Chin Med J (Engl), 2011, 124(12): 1790-1795.

PREV Research progress of differentiating stages of thyroid-associated ophthalmopathy with MRI
NEXT Detection of prostate cancer using magnetic resonance spectroscopy
  


LINK


Tel & Fax: +8610-67113815    E-mail: editor@cjmri.cn